Clinical Trials for Resectable Hepatocellular Carcinoma With High Risk of Recurrence

Find clinical trials for resectable hepatocellular carcinoma with high risk of recurrence. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)

NCT ID: NCT07064681

This clinical trial is studying a group of patients with a type of liver cancer called hepatocellular carcinoma (HCC) that can be removed by surgery but has a high chance of coming back after treat...

Recruiting

Type: observational Locations: Guangzhou, Guangdong, China

Iparomlimab and Tuvonralimab as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With High Risk of Recurrence

NCT ID: NCT06954116

This clinical trial is exploring the use of two medications, iparomlimab and tuvonralimab, as a treatment before surgery for patients with a type of liver cancer called hepatocellular carcinoma (HC...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Wuhan, Hubei, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions